A startup based in the Southern California region is working on innovative methods to prevent and reverse advanced heart failure, a chronic and debilitating condition that is a leading cause of hospitalization among the elderly population. The prognosis for this condition is poor, with only a 50% survival rate within 5 years of diagnosis. The company's primary products consist of implantable hydrogel materials and catheter-based delivery systems designed for minimally invasive delivery to the heart. These implants are aimed at reducing cardiac stress and reshaping the ventricle, ultimately leading to significant improvements in exercise capacity and overall patient well-being.